Table 3.
Results of the pathological examination of the colorectal cancer screening program in Lithuania between 2014 and 2018.
| Pathology Diagnoses | N | % |
|---|---|---|
| Poor-quality specimen | 76 | 0.28 |
| Normal tissue | 1756 | 6.42 |
| Polyp | 4399 | 16.09 |
| Adenoma | 15,653 | 57.25 |
| High-grade dysplasia | 3368 | 12.32 |
| IBD-associated neoplasia | 195 | 0.71 |
| Carcinoma | 1766 | 6.46 |
| Neuroendocrine tumor | 20 | 0.07 |
| Benign nonepithelial tumor | 84 | 0.31 |
| Malignant nonepithelial tumor | 11 | 0.04 |
| Lymphoma | 6 | 0.02 |
| Secondary tumor | 7 | 0.03 |
| Overall | 27,341 | 100 |
IBD—inflammatory bowel disease.